Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02329093

Non-weight Bearing in Hip Joint With Accompanying Joint Pain Might Not Progress Radiographic OA

As we have previously reported, the primary cause of hip OA with accompanying joint pain might be bone alterations which can be microfracture. In order to prove it, it is planned that conservative treatment will be performed on the hip OA patients with accompanying joint pain for the first year. For the second year, if the patients still have joint pain, they will do non-weght bearing walk.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yukio Nakamura

Matsumoto, Nagano, 3908621, Japan

Location status: Recruiting

Location contact

Yukio Nakamura, MD, PhD

CONTACT

[email protected]

+81-263-37-2659

Yukio Nakamura, MD, PhD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hip OA, Joint pain

Exclusion criteria

  • Obvious radipgraphic fracture in hip joint,

Treatment and study plan

To MRI-detecting bone signal changes in radiographic hip OA

Procedure

To examine whether or not non-weight bearing reduced OA progression

Primary outcomes

  1. Bone Signal Changes on the Hip MRI

    Time frame: 1 - 2 years

Sponsors and collaborators

Lead sponsor

Shinshu University

Other

Registry information

Important dates

Study start
2021
Primary completion
2023
Study completion
2026
First posted
Dec 31, 2014
Registry last updated
Sep 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.